What is the impact of SGLT2 inhibitor trials in HFpEF? Read more about What is the impact of SGLT2 inhibitor trials in HFpEF?
Clinical relationship between the heart and the kidneys Read more about Clinical relationship between the heart and the kidneys
Is the initial eGFR dip a cause for concern? Read more about Is the initial eGFR dip a cause for concern?
Why is organ protection crucial in patients with cardiorenal metabolic conditions? Read more about Why is organ protection crucial in patients with cardiorenal metabolic conditions?
Practical tips on initiating SGLT2 inhibitors in elderly/frail patients Read more about Practical tips on initiating SGLT2 inhibitors in elderly/frail patients
Reducing the risk of diabetic ketoacidosis when initiating SGLT2 inhibitors Read more about Reducing the risk of diabetic ketoacidosis when initiating SGLT2 inhibitors
